TY - JOUR
T1 - Erratum
T2 - Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target (Science Translational Medicine (2018) DOI: 10.1126/scitranslmed.aap9840)
AU - Liu, D.
AU - Wong, C. C.
AU - Fu, L.
AU - Chen, H.
AU - Zhao, L.
AU - Li, C.
AU - Zhou, Y.
AU - Zhang, Y.
AU - Xu, W.
AU - Yang, Y.
AU - Wu, B.
AU - Cheng, G.
AU - Lai, P. B.S.
AU - Wong, N.
AU - Sung, J. J.Y.
AU - Yu, J.
N1 - Publisher Copyright:
Copyright © 2018 The Authors.
PY - 2018/9/26
Y1 - 2018/9/26
N2 - In the Research Article "Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target," the missing accession number has been added to the Data and materials availability section of the article. The PDF and HTML (full text) have been corrected.
AB - In the Research Article "Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target," the missing accession number has been added to the Data and materials availability section of the article. The PDF and HTML (full text) have been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85054050405&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054050405&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.aav4522
DO - 10.1126/scitranslmed.aav4522
M3 - Comment/debate
C2 - 30257951
AN - SCOPUS:85054050405
SN - 1946-6234
VL - 10
JO - Science Translational Medicine
JF - Science Translational Medicine
IS - 460
M1 - eaav4522
ER -